The news: The FTC sued the three largest US pharmacy benefit managers (PBMs) over rigging pharma supply chain competition in their favor, resulting in artificially inflated insulin prices for some patients.

The complaint is filed against CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s Optum Rx, which together administer about 80% of prescriptions in the US, per the FTC.
The PBMs have refuted the FTC’s allegations. Express Scripts recently sued the FTC demanding a retraction of the agency’s July report criticizing PBMs’ business practices.

You've read 0 of 2 free articles this month.

Get more articles - create your free account today!

Products

Events & Resources

Topics

Latest Articles

Shoppers hate paying for return shipping more than any other part of the process

Doctors expect longer visits as parents seek clarity about pediatric vaccine guidelines

Lowe’s reaches out to Gen Alpha with new rewards program for kids

Meta faces critical questions as AI spending and regulatory scrutiny intensify

J&J launches direct-to-consumer prescription drug site with lower cash prices

The health and fitness industry’s future is subscription-first, not hardware-led

Scam exposure on social platforms threatens brands

Email is consumers’ top marketing channel, but inbox fatigue threatens ROI

How payment providers should react to OpenAI’s Instant Checkout walkback

Capital One joins finance industry layoff trend, sheds 1,100 Discover workers

About

FTC sues the three largest pharmacy benefit managers for driving up insulin prices

Coverage Areas →

Coverage Areas →

Advertising & Marketing

Health

Ecommerce & Retail

Technology

Financial Services

More Topics

Geographies

EMARKETER

Media Services

Free Content

Contact Us →

Worldwide HQ

Sales Inquiries